Rationale: Wood smoke-associated chronic obstructive pulmonary disease (COPD) is common in women in developing countries but has not been adequately described in developed countries.
INTRODUCTION
Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death, affecting approximately 25-30% of all cigarette smokers. Because of the large number of cigarette smokers, the incidence of this disease is rising and approaching worldwide epidemic proportions (1) . Although COPD is clinically defined as airflow obstruction that is not fully reversible, it is a heterogeneous disease with different phenotypes -airflow obstruction due to parenchymal lung destruction resulting in the loss of elastic recoil (emphysema) and small airway obstruction resulting from peribronchial inflammation and chronic mucous hypersecretion. It is clear that COPD is primarily attributable to cigarette smoking; however, other factors including bacterial and viral infections and environmental air pollutants may affect the development of COPD.
From the global perspective, the magnitude of the health consequences of indoor air pollution rivals that of tobacco use (2) . Epidemiologic studies have linked exposure to wood smoke with increased prevalence of respiratory symptoms and illness in children and adults. Increased respiratory symptoms, decreased pulmonary function, and increased prevalence of asthma, COPD, respiratory failure and cor pulmonale, as well as increased mortality have been associated with wood smoke exposure in various countries across Asia, Africa, and the Americas (3). These studies from developing countries and one from Spain (4) have established that smoke from biomass fuel during cooking activities can cause COPD in women who are non smokers. Although studies of children in the United States suggest that exposure to wood smoke leads to cough, wheeze, and respiratory tract infections (5, 6) association of wood smoke exposure with COPD has not been previously studied in the United States. This association has not been studied among cigarette smokers, a population subgroup already vulnerable to the development of this disease. Further, the interaction of host factors (such as concurrent cigarette smoke exposure, ethnicity, sex, and genetic factors) with wood smoke exposure on this association has not been well-described.
The objective of the present study was to determine whether wood smoke exposure was a significant risk factor for COPD in a cohort of ever-smokers living in an urban area of Southwestern United States and if this association was modified by other host characteristics such as cigarette smoking, ethnicity, sex, or promoter methylation of genes in sputum DNA.
Some of the results of these studies have been reported in the form of an abstract (7). study participants via a questionnaire. Wood smoke exposure was also self-reported as part of the general health survey although no additional details about type, intensity, and duration of wood smoke exposure were obtained. Smoking-related variables included heavy smoking (> 40 pack-years, based on the mean cut point of 39.4) and current smoking status at the time of testing. Body mass index (BMI) was measured using standardized methods (9).
Pre-and post-bronchodilator spirometry were obtained on all subjects by registered respiratory therapists, strictly adhering to the 1994 American Thoracic Society (ATS) guidelines (10). After completion of pre-bronchodilator spirometry, all subjects were given two puffs of albuterol (90 mcg/spray metered dose inhaler) with a LiteAire® dual valve spacer (Thayer Medical Corporation, Tucson, AZ), and spirometry was repeated after 15 minutes. Participants were requested not to take any inhalers for four hours prior to their appointment. Vmax Encore 22 (Viasys Respiratory Care, Yorba Linda, CA) and KoKo (Ferraris Respiratory, Louisville, CO) spirometers were used. Both machines met the 1994 ATS recommendations and were calibrated daily and checked at three different injection speeds, as per the ATS guidelines.
Additionally, respiratory therapists were monitored and periodically re-credentialed, as part of a standardized laboratory proficiency testing plan. Only spirometric tests that meet the ATS criteria for within-maneuver and between-maneuver acceptability were included in the analyses.
Induced sputum was collected and stored in Saccomanno's fixative. Three slides were made for each sputum sample to check for adequacy, as defined by the presence of lung macrophages or Curschmann's spirals (11) . From each study subject adequate sputum samples was taken for DNA isolation by protease digestion followed by phenol chloroform extraction and ethanol precipitation. A methylation specific polymerase chain reaction assay was performed. A panel of eight genes (p16, MGMT, DAPK, RASSF1A, PAX5 α, PAX5 β, GATA4 and GATA5) were selected for analysis of aberrant gene promoter methylation in sputum based on our previous studies establishing their association with risk for lung cancer Page 7 of 31 (12) . Nested methylation-specific polymerase chain reaction was used to detect methylated alleles in DNA recovered from the sputum samples, as previously described (13) . Methylation of cytosines within PCR products was verified by various methods; first, the PCR products amplified from tumor samples have been sequenced by our group and others and show that they capture methylated cytosines. Second, the methylation-specific PCR assays are optimized to be highly specific for the region amplified. Lastly, a subset of sputum samples that gave positive methylation products were also analyzed by a second method using restriction enzyme digestion that can discriminate methylation status of CpGs within the resulting PCR product (12) , (14) .
Outcomes:
Outcome measures and assessment of the exposure variables were obtained at the same visit for all participants. COPD was defined by measurements of percent lung function, presence of airflow obstruction, and chronic bronchitis. Percent lung function: Percent lung function: Our primary outcome was percent predicted value of post-bronchodilator FEV 1 Similarly, multivariable binary logistic regression models were used for binary outcomes.
Covariates considered in the adjusted models included sex, age, heavy smoking, current smoking, obesity, educational status (at least high school or not) and Hispanic ethnicity. All covariates were treated as categorical variables. In Tables 3, 4 , 5 and 7, effect sizes for associations (i.e. Odds ratios and point estimates) are presented for combined risk of two exposures in the third row and individual exposures in the first two rows, as compared to no
exposures. An additive effect between the two exposures was judged to be present when the effect size in row 3 was approximately the sum of the individual effect sizes in rows 1 and 2, which is equivalent to no additive interaction. Two-way regression analyses for multiplicative interactions between exposures on outcomes were also performed. All analyses were conducted in SAS 9.1 (Cary, NC). A two-sided p-value of < 0.05 was considered statistically significant.
Role of the funding source:
The study sponsor played no role in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the paper for publication.
RESULTS

Demographic characteristics
This study involved 1,861 eligible subjects in New Mexico that included 1,503 women (80.8%); 317 Hispanics (17.0%); and 1,079 current smokers (58.0%). Wood smoke exposure was reported by 515 subjects (27.7%); subjects exposed to wood smoke were more likely to be younger than 50 years of age, Hispanic, and current cigarette smokers ( Wood smoke exposure was a significant predictor for all COPD outcomes studied (for all analyses p < 0.001, Table 2 ), after adjustment for cigarette smoking and other covariates in a multivariable analysis. The effect sizes related to wood smoke exposure were generally similar to that of current cigarette smoke exposure, except for chronic bronchitis (Table 2) . NonHispanic whites had higher effect sizes for each of the COPD outcomes studied compared to Hispanics (for all analyses p ≤ 0.03, Table 2 ). In addition, men had higher effect sizes than women for each of the COPD outcomes studied (for all analyses p ≤ 0.002, Table 2 ) except for percent predicted FEV 1 (p = 0.07).
There was an additive effect with current exposure to cigarette smoke and wood smoke for all COPD outcome measures (Table 3) . While a significant multiplicative interaction was noted between non-Hispanics and wood smoke exposure on percent predicted FEV 1 , an additive effect was observed for the remaining outcome measures (Table 4) . Similarly, there was a multiplicative interaction of sex with wood smoke exposure on FEV 1 but an additive effect for the remaining outcome measures (Table 5) . Therefore, three-way interactions between sex or ethnicity, wood smoke and cigarette smoke exposures on percent predicted FEV 1 were analyzed. These analyses demonstrated that men had significantly lower percent predicted FEV 1 than women currently exposed to both wood smoke and cigarette smoke (p for three-way interaction = 0.02). Further, irrespective of cigarette smoke exposure, non-Hispanic whites exposed to wood smoke had lower percent predicted FEV 1 compared to those without exposure to wood smoke. Wood smoke exposure in Hispanics was not associated with a lower percent predicted FEV 1 (p for three-way interaction = 0.001).
Wood smoke exposure was more strongly associated with selected COPD outcomes in the presence of methylated p16 or GATA4 genes in sputum:
Sputum samples of 1,267 subjects (68.1% of eligible cohort) were analyzed for gene promoter methylation of a panel of eight lung cancer-related genes. Analysis of individual genes revealed that methylation of p16 gene was significantly associated with lower percent predicted FEV 1 and possibly higher odds of chronic bronchitis while GATA4 methylation was associated with lower percent predicted FEV 1 after correction for multiple comparisons (Table 6, Table S2 ).
Further, we noted that wood smoke exposure was associated with significantly lower percent predicted FEV 1 in the presence of methylated p16 gene in the sputum (multiplicative interaction p = 0.002; Table 7 footnote). For chronic bronchitis, the odds ratio for the combined risk of p16 methylation and wood smoke was larger than that of each separately. Similarly, wood smoke exposure was associated with lower percent predicted FEV 1 and higher odds of airflow obstruction in the presence of aberrantly methylated GATA4 in the sputum (for all analysis multiplicative interaction p ≤ 0.04; Table 7 ).
Finally, the association between methylation index and each outcome was assessed. Analysis of methylation index, the number of methylated genes in each sputum sample, dichotomized into low (fewer than two genes methylated) and high (two or more genes methylated) showed that high methylation index was significantly associated with lower percent predicted FEV 1 and airflow obstruction (Table S1) .
Alternate analytic strategies:
Our low prevalence of bronchodilator reversibility (approximately 11%), use of postbronchodilator lung function measures, and exclusion of subjects with < 10 pack-year smoking history decreased the misclassification bias resulting from asthma as a cause of airway obstruction. Nevertheless, additional analyses were performed after excluding participants with self-reported asthma (n = 224 or 11%) and similar results were seen. Furthermore, similar results were also observed when airflow obstruction was defined by a post-bronchodilator FEV 1 /FVC ratio below the 5th percentile of the NHANES III predicted value instead of the GOLD criteria or when absolute post-bronchodilator FEV 1 /FVC ratio was analyzed instead of percent predicted FEV 1 .
DISCUSSION
The present study shows that exposure to wood smoke is associated with all COPD phenotypes studied (i.e. low lung function, airflow obstruction, and chronic bronchitis) in a cohort of smokers living in an urban area of Southwestern United States; independent of cigarette smoking. These associations are stronger among current cigarette smokers, non-Hispanic whites and men, as compared to former cigarette smokers, Hispanics and women respectively. In addition, smokers with aberrant promoter methylation of the p16 and GATA4 genes in sputum demonstrate stronger associations between wood smoke exposure and lower lung function than those without these epigenetic changes.
In developed countries, people are exposed to wood smoke in a variety of ways, including smoke from residential heating, cooking stoves, campfires, forest fires, and prescribed fires (17) . Wood burning is an important contributor to particle and gaseous material in ambient air, and in some locations accounts for up to 80% of the airborne particle concentrations during the winter (18) . Measurements in homes heated with wood show that the total particulate matter µm). Exposure to wood smoke in developed countries tends to be at sustained low-levels unlike exposure to cigarette smoke that is short-term but intense with a single cigarette introducing 15-40 mg TPM into the respiratory tract.
Our study contrasts with most studies conducted outside the United States that have focused on non-smokers. Our population of relatively older smokers may be particularly susceptible to the adverse respiratory effects of wood smoke exposure, compared to the general population. This conclusion is supported by the observed additive effect between current cigarette smoke and wood smoke exposures on COPD phenotypes. Furthermore, these epidemiological findings are substantiated by our laboratory findings in which pulmonary inflammation and pathological changes were enhanced in mice concurrently exposed to wood smoke and cigarette smoke compared to cigarette smoke alone (Tesfaigzi, unpublished).
Our findings that New Mexican non-Hispanic whites are at greater risk for wood smokeassociated COPD than Hispanics is generally consistent with previous studies by our group and others showing that non-Hispanic whites in New Mexico may be at greater risk for COPD (22-24). Although the bases for these findings is not known, possible explanations include ethnic differences in the metabolism of wood smoke products, genetic susceptibility to the effects of wood smoke, type of wood burnt in homes, and prevalence of obesity.
Interestingly, our study suggests that men may be at higher risk than women with respect to wood smoke-associated COPD. This may reflect the fact that men may have greater involvement with loading, lighting, and maintaining wood stoves than women in developed countries, resulting in greater wood smoke-exposure.
Aberrant promoter methylation of genes in sputum of smokers was associated with various COPD phenotypes, particularly with reduced lung function. The majority of participants with COPD phenotypes in our cohort have mild to moderate (Stage I and II) disease based on the GOLD criteria. The observed association between high methylation index in sputum and reduced pulmonary function suggests that gene promoter methylation in sputum may be an early biomarker for COPD. However, additional longitudinal studies, including those using COPD phenotypes defined by high resolution computed tomography, are needed to confirm this hypothesis.
In this study, we report a synergistic association for lower lung function between wood smoke exposure and aberrant promoter methylation of the p16 and GATA4 genes in sputum of smokers. We did not find that promoter methylation caused or explained away the wood smoke association. However, both wood smoke and promoter methylation were independent predictors of low lung function. GATA4 is a transcriptional regulator of numerous cell cycle genes (25) and p16 mediates cell cycle arrest and senescence (26) suggesting that these pathways may be disrupted during the development of COPD. Interestingly, each of these variables, i.e., low lung function (27), wood smoke exposure (28) , and methylation of the abovementioned genes (14) are independently associated with increased risk for lung cancer.
Therefore, one would postulate that exposure to wood smoke may enhance the risk for aberrant gene promoter methylation and the development of lung cancer in cigarette smokers. Due to the large number of people exposed to wood smoke world-wide this hypothesis has great public health importance and needs further investigation.
The strengths of our study include its analysis of interactions between wood smoke exposure and cigarette smoke exposures, ethnicity, sex, and epigenetic changes in sputum on COPD outcomes. Additional strengths include use of post-bronchodilator spirometry to define obstruction, strict adherence to the 1994 ATS guidelines in the performance of spirometry, use of NHANES III reference standards, and similar results whether a fixed ratio (i.e. FEV 1 /FVC < 70%) or a statistically-defined lower limit of FEV 1 /FVC ratio (29) was used to define obstruction (16) .
We also recognize several limitations to our study. We cannot exclude differences in alpha-1 antitrypsin deficient status as an alternative explanation to our findings. However, severe alpha-1 antitrypsin deficiency only accounts for 1-2% of cases of COPD. Our study cohort may not be representative of all smokers in New Mexico and in other parts of the United States. However, the smoking behavior in this study is consistent with that observed in representative surveys of the state of New Mexico (30) . Finally, obtaining a binary exposure variable, based on whether or not subjects were exposed to wood smoke from a self-report, overlooks the potential for large variability of exposures and could introduce information bias. We recognize the need to better measure exposure to wood smoke constituents by either validated questionnaire instruments or home exposure monitoring devices to obtain the type, unit amount, and duration of wood smoke the people are exposed to. Therefore, additional research on wood smoke-associated COPD should be performed in cigarette smokers with particular emphasis on understanding the characteristics and dose-response relationship of wood smoke exposure. Although DNA methylation is generally considered to be a stable epigenetic mark, longitudinal studies need to establish the stability of the epigenetic changes in sputum DNA. Furthermore, we analyzed genes that are believed to be primarily associated with lung cancer. Future studies designed to identify genes methylated specifically in COPD will be necessary to develop better biomarkers for this disease. Having successfully established a mouse model that shows enhanced inflammation when exposed to cigarette and wood smoke compared to cigarette or wood smoke alone, studies on identifying epigenetic changes in DNA isolated from lung cells will help identify the genes modified by cigarette and wood smoke exposure. Note 1: All models were adjusted for sex, age categories, Hispanic ethnicity, obesity (BMI ≥ 30 kg/m2), educational status (at least high school or not), heavy smoking history (pack-years > 40 or not), current cigarette smoke exposure and wood smoke exposure, where relevant. Note 2: Exclusion of those with self-reported asthma (n = 224 or 11%) did not significantly alter the results. Note 3: Results for absolute postbronchodilator FEV1/FVC ratio and for airflow obstruction defined by NHANES III criterion were similar to those for FEV1 percent predicted and airflow obstruction defined by GOLD criterion respectively. Note 4: Nonparametric tests using GLM regression models with a Poisson distribution and log link were used to evaluate the continuous FEV1 percent predicted outcome and logistic regression models were used for airflow obstruction and chronic bronchitis. Note 1: The referent group included those currently exposed to neither smoke (n = 585 or 31.4%). Note 2: All models were adjusted for sex, age categories, Hispanic ethnicity, obesity (BMI ≥ 30 kg/m2), educational Status (at least high school or not), and heavy smoking history (pack-years > 40 or not). Note 3: Results for absolute postbronchodilator FEV1/FVC ratio and for airflow obstruction defined by NHANES III criterion were similar to those for FEV1 percent predicted and airflow obstruction defined by GOLD criterion respectively. Note 4: Nonparametric tests using GLM regression models with a Poisson distribution and log link were used to evaluate the continuous FEV1 percent predicted outcome and logistic regression models were used for airflow obstruction and chronic bronchitis. Note 5: Two-way regression analyses showed that multiplicative interactions between wood smoke and cigarette smoke exposures were not significant for any of the above outcome measures (all p ≥ 0.14). However, the effect sizes in row 3 were approximately the sum of the individual effect sizes for rows 1 and 2, indicating an additive effect. ), educational status (at least high school or not), and heavy smoking history (pack-years > 40 or not). Note 3: Results for absolute postbronchodilator FEV1/FVC ratio and for airflow obstruction defined by NHANES III criterion were similar to those for FEV1 percent predicted and airflow obstruction defined by GOLD criterion respectively. Note 4: Nonparametric tests using GLM regression models with a Poisson distribution and log link were used to evaluate the continuous FEV1 percent predicted outcome and logistic regression models were used for airflow obstruction and chronic bronchitis. Note 5: Among the various COPD outcome measures, the only statistically significant multiplicative interaction using two-way regression analyses between non-Hispanic ethnicity and wood smoke exposure was on FEV1 % predicted (p < 0.001). For remaining outcome measures, the effect sizes in row 3 were approximately the sum of the individual effect sizes for rows 1 and 2, indicating an additive effect. Note 1: The referent group included women not exposed to wood smoke (n = 1,078 or 57.6%). Note 2: All models were adjusted for age categories, Hispanic ethnicity, obesity (BMI ≥ 30 kg/m2), educational status (at least high school or not), current cigarette smoking, and heavy smoking history (pack-years > 40 or not). Note 3: Results for absolute postbronchodilator FEV1/FVC ratio and for airflow obstruction defined by NHANES III criterion were similar to those for FEV1 percent predicted and airflow obstruction defined by GOLD criterion respectively. Note 4: Nonparametric tests using GLM regression models with a Poisson distribution and log link were used to evaluate the continuous FEV1 percent predicted outcome and logistic regression models were used for airflow obstruction and chronic bronchitis. Note 5: Among the various COPD outcome measures, the only statistically significant multiplicative interaction using two-way regression analyses between sex and wood smoke exposure was on FEV1 % predicted (p = 0.04). For remaining outcome measures, the effect sizes in row 3 were approximately the sum of the individual effect sizes for rows 1 and 2, indicating an additive effect. Results for absolute postbronchodilator FEV1/FVC ratio and for airflow obstruction defined by NHANES III criterion were similar to those for FEV1 percent predicted and airflow obstruction defined by GOLD criterion respectively. Note 4: Nonparametric tests using GLM regression models with a Poisson distribution and log link were used to evaluate the continuous FEV1 percent predicted outcome and logistic regression models were used for airflow obstruction and chronic bronchitis. Note 5: Two of the panel of eight lung cancer-related genes (p16, MGMT, DAPK, RASSF1A, PAX5 α, PAX5 β, GATA4 and GATA5) were selected for analysis of promoter methylation in sputum. RASSF1A was also significantly and inversely associated with FEV1/FVC ratio and FEV1 % predicted but was not included in the model because of small sample size (10/1267). Note 5: To adjust for multiple comparisons, the p values in the table are to be compared to an α of 0.05 divided by 8 (the number of genes studied); the results for FEV1 % predicted remained significant under Bonferroni correction -a conservative approach for explaining these number of comparisons. Note 1: The referent group included those participants who had <2 methylated gene in sputum (n=760). Note 2: All models were adjusted for sex, age categories, Hispanic ethnicity, obesity (BMI ≥ 30 kg/m2), educational status (at least high school or not), heavy smoking history (pack-years > 40 or not), and current cigarette smoke exposure and wood smoke exposure. Note 3: Results for absolute postbronchodilator FEV1/FVC ratio and for airflow obstruction defined by NHANES III criterion were similar to those for FEV1 percent predicted and airflow obstruction defined by GOLD criterion respectively. Note 4: A panel of eight lung cancer-related genes (p16, MGMT, DAPK, RASSF1A, PAX5 α, PAX5 β, GATA4 and GATA5) were selected for analysis of promoter methylation in sputum.
